Literature DB >> 474036

Osteoporosis in hyperthyroidism estimated by photon absorptiometry.

J Linde, T Friis.   

Abstract

The degree of osteoporosis in hyperthyroidism before and during treatment with carbimazole was studied by photon absorption technique of the right forearm and calcaneus. In addition serum total calcium, serum ionized calcium, serum phosphorus and serum alkaline phosphatase were determined. A group of 96 patients suffering from untreated hyperthyroidism (85 women and 11 men) was studied (79 of these patients were also followed during treatment) and compared to a control group of 157 persons (107 women and 50 men). The women were divided into two groups: less than or equal to 45 years old and more than 45 years old. In all groups untreated hyperthyroid patients showed lower bone densities compared to the control group, but this was only significant in women. During treatment all groups showed a significant increase in density. After 3-6 months of treatment bone density in the calcaneus increased 12% and in the forearm 1.5%; after 6 months - 3 years 33% and 31%, respectively. At that time bone density was normalized. There was no correlation between bone density in hyperthyroid patients and duration and severity of the disease. The biochemical changes were characterised by increases in serum alkaline phosphatase (26%), serum total calcium (16%) and serum ionized calcium concentration (17%) in cases of untreated hyperthyroidism. Serum phosphorus concentration did not change. A correlation was found between elevation of the alkaline phosphatase and decreased bone density.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 474036     DOI: 10.1530/acta.0.0910437

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  9 in total

Review 1.  Calcium metabolism in thyroid disease.

Authors:  G Benker; N Breuer; R Windeck; D Reinwein
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

2.  Bone mineralization and calciotropic hormones in children with hyperthyroidism. Effects of methimazole therapy.

Authors:  G Saggese; S Bertelloni; G I Baroncelli
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

3.  Risks Associated with Treating Hypothyroidism: Potential hazards of L-thyroxine therapy.

Authors:  H C Gerstein
Journal:  Can Fam Physician       Date:  1992-06       Impact factor: 3.275

4.  Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH.

Authors:  A N Gam; G F Jensen; K Hasselstrøm; M Olsen; K S Nielsen
Journal:  J Endocrinol Invest       Date:  1991-06       Impact factor: 4.256

5.  Spinal bone mass after long-term treatment with L-thyroxine in postmenopausal women with thyroid cancer and chronic lymphocytic thyroiditis.

Authors:  F Hawkins; D Rigopoulou; K Papapietro; M B Lopez
Journal:  Calcif Tissue Int       Date:  1994-01       Impact factor: 4.333

6.  Bone mineral metabolism and thyroid replacement therapy in congenital hypothyroid infants and young children.

Authors:  G Weber; S Mora; A Bellini; M Bosco; C Prinster; V Siragusa; B di Natale; G Chiumello
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

7.  Thyroid dysfunction in an adult female population: A population-based study of Latin American Vertebral Osteoporosis Study (LAVOS) - Puerto Rico site.

Authors:  Loida A González-Rodríguez; Marcos E Felici-Giovanini; Lillian Haddock
Journal:  P R Health Sci J       Date:  2013-06       Impact factor: 0.705

Review 8.  Bone disease in thyrotoxicosis.

Authors:  P Amaresh Reddy; C V Harinarayan; Alok Sachan; V Suresh; G Rajagopal
Journal:  Indian J Med Res       Date:  2012-03       Impact factor: 2.375

9.  Metabolic and clinical consequences of hyperthyroidism on bone density.

Authors:  Jagoda Gorka; Regina M Taylor-Gjevre; Terra Arnason
Journal:  Int J Endocrinol       Date:  2013-07-22       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.